These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31535835)

  • 1. The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis.
    Al Shidhani K; O’Reilly R; Javadpour S; O’Sullivan N; McNally P; Cox DW
    Ir Med J; 2019 Jun; 112(6):946. PubMed ID: 31535835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre.
    Proesmans M; Balinska-Miskiewicz W; Dupont L; Bossuyt X; Verhaegen J; Høiby N; de Boeck K
    Eur Respir J; 2006 May; 27(5):937-43. PubMed ID: 16707392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
    Dassios TG; Katelari A; Doudounakis S; Dimitriou G
    Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1999 Sep; 28(3):159-66. PubMed ID: 10495331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.
    Ahlgren HG; Benedetti A; Landry JS; Bernier J; Matouk E; Radzioch D; Lands LC; Rousseau S; Nguyen D
    BMC Pulm Med; 2015 Jun; 15():67. PubMed ID: 26093634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1997 May; 23(5):330-5. PubMed ID: 9168506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
    Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
    Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
    Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
    J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M
    J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.
    Johansen HK; Kovesi TA; Koch C; Corey M; Høiby N; Levison H
    Pediatr Pulmonol; 1998 Aug; 26(2):89-96. PubMed ID: 9727758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients.
    de Vrankrijker AM; Brimicombe RW; Wolfs TF; Heijerman HG; van Mansfeld R; van Berkhout FT; Willems RJ; Bonten MJ; van der Ent CK
    Clin Microbiol Infect; 2011 Mar; 17(3):382-5. PubMed ID: 20807225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.